Clinical trials
Completed Phase 2 Dermatomyositis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 3 |
| Kezar Life Sciences, Inc. | 2 |
| Pfizer | 2 |
| Alison Ehrlich | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Chester Oddis | 1 |
| Idera Pharmaceuticals, Inc. | 1 |
| Karolinska Institutet | 1 |
| Lakefront Biotherapeutics NV | 1 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dermatomyositis | 20 |
| Polymyositis | 10 |
| Myositis | 5 |
| Muscular Diseases | 2 |
| Musculoskeletal Diseases | 2 |
| Calcinosis | 1 |
| Cardiovascular Diseases | 1 |
| Connective Tissue Diseases | 1 |
| Inflammation | 1 |
| Muscle Weakness | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.